Review maps GAN models used for de novo peptide drug design

The wire

1. 01A review in Probiotics and Antimicrobial Proteins summarizes GAN architectures including CGAN, WGAN-GP and MPOGAN applied to designing antimicrobial, antiviral and anticancer peptide sequences.
2. 02Machine-generated candidates are entering peptide pipelines, so readers tracking new peptide chemistry should know how thin the validation is behind reported activity gains.
3. 03The authors note most results stop at in silico evaluation or early in vitro assays and propose LLM-assisted annotation and closed-loop AI-experimental platforms as next steps.

From the source

GANs in Peptide Drug Discovery: From De Novo Design to Multi-Property Optimization and Clinical Translation

Probiotics and antimicrobial proteins · 2026 Aug 31 · Chu Y, Zhang S, Pan B et al.